Denali Therapeutics Inc. (DNLI) has 209 open-market insider trades by 13 insiders since 2017. Over the last six months insiders net sold $108K. The most active filer is Ryan J. Watts, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Crestline Investors, Inc. | 10% Owner | — | 2 | $177.9M | 2020-06-05 |
| Douglas K. Bratton | 10% Owner | — | 3 | $160.1M | 2021-02-12 |
| Crestline Management, LP | 10% Owner | — | 1 | $91.4M | 2020-08-12 |
| Marc Tessier-Lavigne | Dir | — | 13 | $38.6M | 2025-06-03 |
| Ryan J. Watts | CEOPres | — | 57 | $36.9M | 2026-08-12 |
| Alexander O. Schuth | Secretary | — | 50 | $18.7M | 2026-09-01 |
| Carole Ho | — | — | 52 | $14.2M | 2025-08-13 |
| Bratton Capital Management, L.P. | 10% Owner | — | 1 | $12.0M | 2020-06-30 |
| Steve E. Krognes | Dir | — | 18 | $11.8M | 2026-06-03 |
| Bratton Capital Inc. | 10% Owner | — | 1 | $10.4M | 2020-12-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Peter Scott Chin | — | Sell | $37K | 2026-09-04 |
| Nancy Thornberry | Director | Sell | $262K | 2026-09-02 |
| Alexander O. Schuth | Secretary | Sell | $65K | 2026-09-01 |
| Alexander O. Schuth | Secretary | Sell | $72K | 2026-08-11 |
| Ryan J. Watts | President | Sell | $581K | 2026-01-06 |
| Alexander O. Schuth | Secretary | Sell | $284K | 2026-01-06 |
Companies that share insiders with DNLI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Carole Ho | Chief Medical Officer | Sell | $52K | 2025-08-12 |
| Alexander O. Schuth | Secretary | Sell | $40K | 2025-08-12 |
| Ryan J. Watts | CEO & President | Sell | $7.4M | 2025-07-09 |
| Steve E. Krognes | Director | Sell | $139K | 2025-01-07 |
| Carole Ho | — | Sell | $617K | 2025-01-06 |
| Ryan J. Watts | CEO & President | Sell | $1.5M | 2025-01-06 |
| Vicki L. Sato | Director | Sell | $129K | 2025-01-02 |
| Steve E. Krognes | Director | Sell | $608K | 2024-12-31 |
| David P. Schenkein | Director | Sell | $3.9M | 2024-11-11 |